H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 63 Citations 16,093 159 World Ranking 1484 National Ranking 90
Medicine D-index 82 Citations 25,528 275 World Ranking 8741 National Ranking 405

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Immune system
  • Gene

His scientific interests lie mostly in Immunology, Immune system, Internal medicine, B cell and Autoimmunity. His work in Memory B cell, Plasma cell, Autoantibody, Autoimmune disease and Antibody is related to Immunology. His Autoimmune disease research incorporates themes from Systemic lupus erythematosus and Rheumatoid arthritis.

Thomas Dörner has researched B cell in several fields, including Lupus erythematosus, Naive B cell and Rituximab. His research integrates issues of Somatic hypermutation and Follicular dendritic cells in his study of Autoimmunity. His studies in Regulatory B cells integrate themes in fields like Therapeutic approach, IL-2 receptor, EBI3, CD40 and Interleukin 12.

His most cited work include:

  • Competence and competition: the challenge of becoming a long-lived plasma cell. (781 citations)
  • Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009 (685 citations)
  • Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis (649 citations)

What are the main themes of his work throughout his whole career to date?

Thomas Dörner mainly focuses on Immunology, Internal medicine, B cell, Antibody and Rheumatoid arthritis. Immunology is represented through his Autoimmunity, Autoantibody, Immune system, Rituximab and Cytokine research. His work on Rheumatology and Systemic lupus erythematosus as part of general Internal medicine study is frequently linked to In patient, therefore connecting diverse disciplines of science.

His B cell study integrates concerns from other disciplines, such as Molecular biology, Naive B cell and CD19. His Antibody research includes elements of Bone marrow, Pathology and Antigen. His study in Rheumatoid arthritis is interdisciplinary in nature, drawing from both Disease and Arthritis.

He most often published in these fields:

  • Immunology (47.61%)
  • Internal medicine (35.21%)
  • B cell (21.13%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (35.21%)
  • Immunology (47.61%)
  • B cell (21.13%)

In recent papers he was focusing on the following fields of study:

His main research concerns Internal medicine, Immunology, B cell, Systemic lupus erythematosus and Rheumatoid arthritis. His work on Cohort, Rheumatology and Rheumatism is typically connected to In patient as part of general Internal medicine study, connecting several disciplines of science. He undertakes multidisciplinary studies into Immunology and TLR9 in his work.

The study incorporates disciplines such as Molecular biology, CD40 and CD19 in addition to B cell. His Systemic lupus erythematosus research is multidisciplinary, relying on both Lupus nephritis, Drug development and Lupus erythematosus. The concepts of his Rheumatoid arthritis study are interwoven with issues in Disease and Arthritis.

Between 2018 and 2021, his most popular works were:

  • Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. (421 citations)
  • Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) (345 citations)
  • EULAR recommendations for the management of antiphospholipid syndrome in adults (215 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Disease

Thomas Dörner spends much of his time researching Internal medicine, Systemic lupus erythematosus, Cohort, Rheumatism and Lupus erythematosus. His research integrates issues of Disease cluster and Placebo in his study of Internal medicine. His Systemic lupus erythematosus study combines topics in areas such as Clinical study design and Drug development.

His research in Lupus erythematosus intersects with topics in Interferon, CD40 and Gene expression profiling. His Interleukin research is classified as research in Immunology. His Immunology study frequently draws connections to other fields, such as Receptor.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

George K Bertsias;Maria Tektonidou;Zahir Amoura;Martin Aringer.
Annals of the Rheumatic Diseases (2012)

1012 Citations

Competence and competition: the challenge of becoming a long-lived plasma cell.

Andreas Radbruch;Gwendolin Muehlinghaus;Elke O. Luger;Ayako Inamine.
Nature Reviews Immunology (2006)

986 Citations

IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases

Ping Shen;Toralf Roch;Vicky Lampropoulou;Richard A. O’Connor.
Nature (2014)

801 Citations

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009

D. E. Furst;E. C. Keystone;J. Braun;F. C. Breedveld.
Annals of the Rheumatic Diseases (2006)

685 Citations

Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology.

Eva Schrezenmeier;Thomas Dörner.
Nature Reviews Rheumatology (2020)

644 Citations

Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

Ronald van Vollenhoven;Marta Mosca;George Bertsias;David Isenberg.
Annals of the Rheumatic Diseases (2014)

511 Citations

Guidelines for the use of flow cytometry and cell sorting in immunological studies

Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Mübeccel Akdis.
European Journal of Immunology (2017)

476 Citations

Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus.

Annett M. Jacobi;Marcus Odendahl;Karin Reiter;Anne Bruns.
Arthritis & Rheumatism (2003)

469 Citations

High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire.

Brandon J DeKosky;Gregory C Ippolito;Ryan P Deschner;Jason J Lavinder.
Nature Biotechnology (2013)

408 Citations

Immunopathogenic mechanisms of systemic autoimmune disease

Marie Wahren-Herlenius;Thomas Dörner.
The Lancet (2013)

376 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Thomas Dörner

David A. Isenberg

David A. Isenberg

University College London

Publications: 85

Andreas Radbruch

Andreas Radbruch

German Rheumatism Research Centre

Publications: 72

Falk Hiepe

Falk Hiepe

Humboldt-Universität zu Berlin

Publications: 71

Paul Emery

Paul Emery

University of Leeds

Publications: 69

Andrea Doria

Andrea Doria

University of Padua

Publications: 59

Xavier Mariette

Xavier Mariette

University of Paris-Sud

Publications: 55

Yoshiya Tanaka

Yoshiya Tanaka

University of Occupational and Environmental Health Japan

Publications: 53

Josef S. Smolen

Josef S. Smolen

Medical University of Vienna

Publications: 45

Ronald F. van Vollenhoven

Ronald F. van Vollenhoven

University of Amsterdam

Publications: 44

Marie Wahren-Herlenius

Marie Wahren-Herlenius

Karolinska Institute

Publications: 44

Arjan Vissink

Arjan Vissink

University Medical Center Groningen

Publications: 43

Daniel J. Wallace

Daniel J. Wallace

University of California, Los Angeles

Publications: 42

Jacques-Olivier Pers

Jacques-Olivier Pers

University of Western Brittany

Publications: 42

Roland Jonsson

Roland Jonsson

University of Bergen

Publications: 41

Dimitrios T. Boumpas

Dimitrios T. Boumpas

National and Kapodistrian University of Athens

Publications: 41

Michelle Petri

Michelle Petri

Johns Hopkins University School of Medicine

Publications: 40

Something went wrong. Please try again later.